Meyka Pro banner
Waters Corporation

Waters Corporation (WAT) Stock Overview

Explore Waters Corporation’s financial performance, market position, analyst ratings, and future outlook.

WATNYSE
HealthcareMedical - Diagnostics & Research
$410.70
$6.010(1.49%)
U.S. Market opens in 58h 46m

Waters Corporation (WAT)

Meyka AI Score

Z

Key Financials

Market Cap30.7B
P/E Ratio102.48
EPS (TTM)$13.68
ROE0.02%
Fundamental Analysis

AI Price Forecasts

1 Month$410.19
3 Months$364.87
1 Year Target$369.67

WAT Stock Analysis & Investment Overview (NYSE)

Our AI-powered analysis of Waters Corporation (NYSE: WAT) gives investors deep insight into how the stock performs on the NYSE exchange, its growth potential, and its market positioning. With a Meyka AI Score of B+, Waters Corporation's NYSE-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of WAT on the NYSE shows an RSI of 59.60, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $369.67 for the NYSE listing.

Key metrics behind Waters Corporation's NYSE-traded stock include a P/E ratio of 102.48 and a market capitalization of 30.7B. Combined with our AI analysis, these give both institutional and retail investors a clear view of WAT on the NYSE.

Price Performance (NYSE: WAT)

1-Day Change
1.50%
5-Day Change
-1.01%
1-Month Change
11.76%
3-Month Change
20.46%
6-Month Change
23.23%
Year-to-Date (YTD) Change
8.15%
1-Year Change
41.43%
3-Year Change
53.75%
5-Year Change
1.98%
All-Time (Max) Change
10763.34%

Contact Information

508 478 2000
34 Maple Street, Milford, MA, 01757

Company Facts

79,000 Employees
IPO DateNov 17, 1995
CountryUS
Actively Trading

Frequently Asked Questions